search
Back to results

Intrapulmonary Percussive Ventilation (IPV) Versus Nasal Continuous Positive Airway Pressure Ventilation (nCPAP) in Transient Respiratory Distress of the Newborn (HFPV)

Primary Purpose

Respiratory Distress Syndrome, Newborn

Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Nasal Continuous Positive Airway Pressure ventilation
Intrapulmonary Percussive Ventilation
Sponsored by
University Hospital, Bordeaux
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Respiratory Distress Syndrome, Newborn focused on measuring HFPV, neonatal respiratory distress

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Caesarean newborn
  • Gestational age ≥ 35 weeks
  • Weight ≥ 2 kg
  • SaO2 < 90% after 10 min of life
  • Silverman score ≥ 5
  • Treated less than 20 min after birth
  • Social security affiliation (parents)
  • Informed consent signed (parents)

Exclusion Criteria:

  • Thoracic retraction
  • Congenital intrathoracic malformations
  • Meconium aspiration
  • Early neonatal infections with hemodynamic troubles
  • Severe neonatal asphyxia
  • Polymalformative syndrome

Sites / Locations

  • Néonatalogie - Maternité - Hôpital Pellegrin

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

nHFPV

nCPAP

Arm Description

Intrapulmonary Percussive Ventilation

Nasal Continuous Positive Airway Pressure ventilation

Outcomes

Primary Outcome Measures

Difference in time (min) required to normalize the respiratory distress (modified Silverman score = 0, no need for oxygen, RF < 50 bpm and SaO2 > 92%) between the two ventilatory modes

Secondary Outcome Measures

Number of pneumothorax, lung infections, transfer to intensive care service, time of oxygenotherapy

Full Information

First Posted
November 9, 2007
Last Updated
May 12, 2010
Sponsor
University Hospital, Bordeaux
search

1. Study Identification

Unique Protocol Identification Number
NCT00556738
Brief Title
Intrapulmonary Percussive Ventilation (IPV) Versus Nasal Continuous Positive Airway Pressure Ventilation (nCPAP) in Transient Respiratory Distress of the Newborn
Acronym
HFPV
Official Title
Intrapulmonary Percussive Ventilation and Nasal Continuous Positive Airway Pressure Ventilation in Transient Respiratory Distress of the Newborn: A Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
May 2010
Overall Recruitment Status
Completed
Study Start Date
November 2007 (undefined)
Primary Completion Date
December 2009 (Actual)
Study Completion Date
December 2009 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
University Hospital, Bordeaux

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
During caesarean section, transient respiratory distress which occurs frequently (3%) with possible complications are at present managed by non invasive nasal continuous positive airway pressure ventilation (nCPAP) associated with oxygen therapy. Intrapulmonary Percussive Ventilation (IPV) is a non-invasive ventilatory mode used in some intensive care units to treat some respiratory distress syndrome of the newborn with a good tolerance, but without evaluation in prospective studies
Detailed Description
Principal Objective: To show that IPV ventilation can decrease the duration of transient respiratory distress as well as the risk of complications. Secondary Objective: Comparison between the two groups regarding: Length of oxygen therapy, complications (pneumothorax, pulmonary infections), need for intensive care hospitalization Study design: Open, prospective randomized trial. Inclusion criteria: Neonates with gestational age ≥ 35 weeks and weight ≥ 2000g, caesarean section, respiratory distress syndrome (modified Silverman score > 5, SpO2 < 90%), management within 20 minutes after birth. Exclusion criteria: clinical thoracic retraction, congenital lung malformation, meconium aspiration, neonatal infection, other congenital malformations. Study plan: After the screening evaluation and written consent document, neonates will be randomized into two groups: nCPAP ventilation or IPV. During the 6 hours after randomization, clinical data will be monitored: cardiac and respiratory frequency (CF -RF), saturation (SaO2), oxygenotherapy, Silverman Score. Then, neonates will be supervised 3 days after normalization of the respiratory distress. Number of subjects: 100 (50 in each group)

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Respiratory Distress Syndrome, Newborn
Keywords
HFPV, neonatal respiratory distress

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
100 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
nHFPV
Arm Type
Experimental
Arm Description
Intrapulmonary Percussive Ventilation
Arm Title
nCPAP
Arm Type
Active Comparator
Arm Description
Nasal Continuous Positive Airway Pressure ventilation
Intervention Type
Procedure
Intervention Name(s)
Nasal Continuous Positive Airway Pressure ventilation
Intervention Description
Nasal Continuous Positive Airway Pressure ventilation
Intervention Type
Procedure
Intervention Name(s)
Intrapulmonary Percussive Ventilation
Intervention Description
Intrapulmonary Percussive Ventilation
Primary Outcome Measure Information:
Title
Difference in time (min) required to normalize the respiratory distress (modified Silverman score = 0, no need for oxygen, RF < 50 bpm and SaO2 > 92%) between the two ventilatory modes
Time Frame
Within the first 6 hours after birth
Secondary Outcome Measure Information:
Title
Number of pneumothorax, lung infections, transfer to intensive care service, time of oxygenotherapy
Time Frame
Within the first 72 hours after birth

10. Eligibility

Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Caesarean newborn Gestational age ≥ 35 weeks Weight ≥ 2 kg SaO2 < 90% after 10 min of life Silverman score ≥ 5 Treated less than 20 min after birth Social security affiliation (parents) Informed consent signed (parents) Exclusion Criteria: Thoracic retraction Congenital intrathoracic malformations Meconium aspiration Early neonatal infections with hemodynamic troubles Severe neonatal asphyxia Polymalformative syndrome
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Clothilde Bertrand, Dr
Organizational Affiliation
University Hospital, Bordeaux
Official's Role
Principal Investigator
Facility Information:
Facility Name
Néonatalogie - Maternité - Hôpital Pellegrin
City
Bordeaux
ZIP/Postal Code
33076
Country
France

12. IPD Sharing Statement

Citations:
PubMed Identifier
20963833
Citation
Dumas De La Roque E, Bertrand C, Tandonnet O, Rebola M, Roquand E, Renesme L, Elleau C. Nasal high frequency percussive ventilation versus nasal continuous positive airway pressure in transient tachypnea of the newborn: a pilot randomized controlled trial (NCT00556738). Pediatr Pulmonol. 2011 Mar;46(3):218-23. doi: 10.1002/ppul.21354. Epub 2010 Oct 20.
Results Reference
derived

Learn more about this trial

Intrapulmonary Percussive Ventilation (IPV) Versus Nasal Continuous Positive Airway Pressure Ventilation (nCPAP) in Transient Respiratory Distress of the Newborn

We'll reach out to this number within 24 hrs